RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los inhibidores de la PDE4 en pac con EPOC https://t.co/YISIfTjHZx
(Cochrane) Seguridad y eficacia de los inhibidores de la PDE4 en pac con EPOC https://t.co/YISIfTjHZx
Utilidad delos inhibidores de la fosfodiesterasa 4 para la enfermedad pulmonar obstructiva crónica, rev. Cochrane https://t.co/lCGVDlu5QY
Quels sont les bénéfices et les risques des inhibiteurs de la phosphodiestérase 4 chez les patients atteints de br… https://t.co/5NreyXpIhq
RT @KFSHRC_Research: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/rHIGjgYto6 https://t.co/Ar3i95WN…
RT @KFSHRC_Research: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/rHIGjgYto6 https://t.co/Ar3i95WN…
RT @KFSHRC_Research: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/rHIGjgYto6 https://t.co/Ar3i95WN…
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/rHIGjgYto6 https://t.co/Ar3i95WNBp
RT @CochraneAirways: Here's a #blogshot for #Cochrane Review Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https…
RT @CochraneAirways: New #CochraneEvidence: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/QhuUSpe5VM
Small change. Updated @CochraneAirways #COPD review shows marginal gain in symptoms & QoL with PDE4s https://t.co/DIzpPYfoXs
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los inhibidores de la PDE4 en la EPOC https://t.co/5VaI6MHc6c Algunas luces, muchas…
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de los inhibidores de la PDE4 en la EPOC https://t.co/5VaI6MHc6c Algunas luces, muchas…
RT @CochraneAirways: Here's a #blogshot for #Cochrane Review Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https…
(Cochrane) Los i-PDE4 en EPOC mejoran la función pulmonar y exacerbaciones; pero no la Calidad de vida o síntomas https://t.co/RN9dvQ3ewi
"In people with COPD, PDE4 inhibitors offered benefit over placebo in improving lung function and reducing the likelihood of exacerbations" https://t.co/ed7ABHO7v2
Los inhibidores de la fosfodiesterasa 4 pueden mejorar la función pulmonar y reducir las de exacerbaciones en EPOC. https://t.co/5uLYmkDflE
Recién salidita del horno!! Inhibidores de fosfodiesterasa-4 (PDE4) como Roflumilast y cilomilast para EPOC. Una... https://t.co/DnSz82RwLp
In people with chronic obstructive pulmonary disease (COPD), what are the benefits and… https://t.co/sV9gRTfrc9
RT @CochraneAirways: New #CochraneEvidence: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/QhuUSpe5VM
RT @CochraneAirways: Here's a #blogshot for #Cochrane Review Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https…
New #CochraneEvidence: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/QhuUSpe5VM
Here's a #blogshot for #Cochrane Review Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease https://t.co/QhuUSpe5VM https://t.co/fktuk3Twsf
CochraneLibrary: In people with chronic obstructive pulmonary disease (COPD), what are the benefits and risks of… https://t.co/wUPCNVXbiv https://t.co/gWurouiAmP
(Cochrane) Seguridad y eficacia de los inhibidores de la PDE4 en la EPOC https://t.co/5VaI6MHc6c Algunas luces, muchas sombras...
New NNT→Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. https://t.co/hqYiUkdzW6
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. https://t.co/ksuaK2Torf